What is PharmPak?
PharmPak Inc., operating since 1983, specializes in providing ready-to-dispense medications to enhance patient compliance and therapeutic outcomes. Their comprehensive services include repackaging bulk medications and supplying both prescription and over-the-counter drugs. Key offerings feature unit-dose blister-pack dispensing and customized labeling, catering to a diverse clientele such as family planning centers, surgery centers, senior care facilities, and various health departments. PharmPak's commitment to quality customer service and adherence to federal regulations ensures a streamlined experience for healthcare providers.
How much funding has PharmPak raised?
PharmPak has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PharmPak
PPP
Public-Private Partnership
What's next for PharmPak?
With a substantial capital base indicated by $150K, PharmPak is well-positioned for its next phase of strategic development. The recent major strategic investment signals confidence from backers in the company's business model and its capacity to scale operations. This backing will likely fuel advancements in their medication dispensing technology, expansion into new healthcare markets, and further enhancement of their compliance and customer service offerings. The company's focus on improving medication management solutions is expected to drive continued innovation and market leadership.
See full PharmPak company page
